Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1269
Biosurgery Market is poised to value over CAGR of over 5.5% during the forecast period 2022 to 2028. The growth of the geriatric population, coupled with the rise in the sheer number of sports-related injuries and surgeries, the need for adequate patient blood loss management, the increase in the clearance of biosurgery products by regulatory authorities are all factors that have played a role in the potential growth of the market. The market has much economic scope as new products and applications have been introduced. These biosurgery products are found in numerous applications ranging from gynecological surgery, orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, urological surgery, thoracic surgery and reconstructive surgery. Based on the segmentation, the market involves products such as surgical sealants and adhesives, soft tissue attachments, staple line reinforcement agents, bone graft substitutes, and hemostatic agents and adhesion barriers. The growing demand for hydrogel-based polymeric sealants has also been instrumental in the meteoric augmentation of the biosurgery market. The Asia Pacific market region has been anticipated to register a high CAGR value over the forecast time frame. The APAC market is growing rapidly particularly in terms of biosurgery products. It's important to note that the ever-expanding healthcare expenditure, rising need for managing blood loss effectively and the growing number of surgical procedures are factors which have enhanced the market growth in the region. Large networks of key market players as well as the presence of native players and the growing prevalence of biosurgery products, are aspects which have been instrumental to the potential of the market. Therefore, the Asia Pacific region holds a substantial global biosurgery market share. Major players included in the Biosurgery Market: • Johnson & Johnson • Baxter International Inc. • Medtronic Plc • Becton, Dickinson & Co. • Tissue Regenix Group Plc • Stryker Corp. • Integra Lifesciences Holdings Corp. • CSL Ltd. • Hemostasis LLC. • Pfizer Inc. • Cyrolife Inc. • Zimmer Biomet • Kuros Biosciences AG • Orthofix Medical Inc. • Smiths & Nephew Plc. • Tissue Regenix Group Plc • Betatech Medical • Meril Lifesciences Pvt. Ltd. • RTI Surgicals • Samyang Holdings Corp. (Note: The list of the major players will be updated with the latest market scenario and trends) Biosurgery Market Segmentation: By Product Type • Bone Graft Substitutes o Demineralized bone matrix o Synthetic Bone Grafts o Bone Morphogenetic Proteins o Other Bone-Graft Substitutes • Soft-tissue attachments o Synthetic meshes o Biological meshes • Allografts • Xenografts • Hemostatic agents o Thrombin-based hemostatic agents o Oxidized regenerated cellulose-based hemostatic agents o Combination hemostatic agents • Surgical sealants and adhesives o Natural/Biological Sealants and Adhesives • Natural/Biological Sealants and Adhesives, By Type • Fibrin Sealants • Collagen-Based Sealants • Gelatin-Based Sealants • Albumin-Based Sealants • Other Natural/Biological Sealants • Natural/Biological Sealants and Adhesives, By Origin • Human Blood-Based Sealants and Adhesives • Animal-Based Sealants and Adhesives o Synthetic and Semi-Synthetic Sealants and Adhesives • Peg Hydrogels • Cyanoacrylate-Based Sealants and Adhesives • Urethane-Based Sealants and Adhesives • Other Synthetic and Semi-Synthetic Sealants and Adhesives • Adhesion Barriers o Synthetic Adhesion Barriers • Hyaluronic Acid-Based Adhesion Barriers • Regenerated Cellulose-Based Adhesion Barriers • Peg-Based Adhesion Barriers • Other Synthetic Adhesion Barriers o Natural Adhesion Barriers • Collagen & Protein Adhesion Barriers • Fibrin-Based Adhesion Barriers • Staple-Line Reinforcement Agents By Application • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Reconstructive Surgery • Gynecological Surgery • Urological Surgery • Thoracic Surgery • Others By End User • Hospitals • Clinics • Others By Region: • North America • Europe • Asia Pacific • Latin America • The Middle East and Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global bio surgery market by product type, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and the Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The growth of the geriatric population, coupled with the rise in the sheer number of sports-related injuries and surgeries, the need for adequate patient blood loss management, the increase in the clearance of biosurgery products by regulatory authorities are all factors that have played a role in the potential growth of the market. The market has much economic scope as new products and applications have been introduced. These biosurgery products are found in numerous applications ranging from gynecological surgery, orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, urological surgery, thoracic surgery and reconstructive surgery.
Based on the segmentation, the market involves products such as surgical sealants and adhesives, soft tissue attachments, staple line reinforcement agents, bone graft substitutes, and hemostatic agents and adhesion barriers. The growing demand for hydrogel-based polymeric sealants has also been instrumental in the meteoric augmentation of the biosurgery market.
The Asia Pacific market region has been anticipated to register a high CAGR value over the forecast time frame. The APAC market is growing rapidly particularly in terms of biosurgery products. It's important to note that the ever-expanding healthcare expenditure, rising need for managing blood loss effectively and the growing number of surgical procedures are factors which have enhanced the market growth in the region. Large networks of key market players as well as the presence of native players and the growing prevalence of biosurgery products, are aspects which have been instrumental to the potential of the market. Therefore, the Asia Pacific region holds a substantial global biosurgery market share.
Major players included in the Biosurgery Market: • Johnson & Johnson • Baxter International Inc. • Medtronic Plc • Becton, Dickinson & Co. • Tissue Regenix Group Plc • Stryker Corp. • Integra Lifesciences Holdings Corp. • CSL Ltd. • Hemostasis LLC. • Pfizer Inc. • Cyrolife Inc. • Zimmer Biomet • Kuros Biosciences AG • Orthofix Medical Inc. • Smiths & Nephew Plc. • Tissue Regenix Group Plc • Betatech Medical • Meril Lifesciences Pvt. Ltd. • RTI Surgicals • Samyang Holdings Corp. (Note: The list of the major players will be updated with the latest market scenario and trends)
Biosurgery Market Segmentation:
By Product Type • Bone Graft Substitutes o Demineralized bone matrix o Synthetic Bone Grafts o Bone Morphogenetic Proteins o Other Bone-Graft Substitutes • Soft-tissue attachments o Synthetic meshes o Biological meshes • Allografts • Xenografts • Hemostatic agents o Thrombin-based hemostatic agents o Oxidized regenerated cellulose-based hemostatic agents o Combination hemostatic agents • Surgical sealants and adhesives o Natural/Biological Sealants and Adhesives • Natural/Biological Sealants and Adhesives, By Type • Fibrin Sealants • Collagen-Based Sealants • Gelatin-Based Sealants • Albumin-Based Sealants • Other Natural/Biological Sealants • Natural/Biological Sealants and Adhesives, By Origin • Human Blood-Based Sealants and Adhesives • Animal-Based Sealants and Adhesives o Synthetic and Semi-Synthetic Sealants and Adhesives • Peg Hydrogels • Cyanoacrylate-Based Sealants and Adhesives • Urethane-Based Sealants and Adhesives • Other Synthetic and Semi-Synthetic Sealants and Adhesives • Adhesion Barriers o Synthetic Adhesion Barriers • Hyaluronic Acid-Based Adhesion Barriers • Regenerated Cellulose-Based Adhesion Barriers • Peg-Based Adhesion Barriers • Other Synthetic Adhesion Barriers o Natural Adhesion Barriers • Collagen & Protein Adhesion Barriers • Fibrin-Based Adhesion Barriers • Staple-Line Reinforcement Agents
By Application • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Reconstructive Surgery • Gynecological Surgery • Urological Surgery • Thoracic Surgery • Others
By End User • Hospitals • Clinics • Others
By Region:
• North America • Europe • Asia Pacific • Latin America • The Middle East and Africa
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Biosurgery Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biosurgery Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Biosurgery Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Biosurgery Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Bone Graft Substitutes 7.1.1. Demineralized bone matrix 7.1.2. Synthetic Bone Grafts 7.1.3. Bone Morphogenetic Proteins 7.1.4. Other Bone-Graft Substitutes 7.2. Soft-tissue attachments 7.2.1. Synthetic meshes 7.2.2. Biological meshes 7.2.2.1. Allografts 7.2.2.2. Xenografts 7.3. Hemostatic agents 7.3.1. Thrombin-based hemostatic agents 7.3.2. Oxidized regenerated cellulose-based hemostatic agents 7.3.3. Combination hemostatic agents 7.4. Surgical sealants and adhesives 7.4.1. Natural/Biological Sealants and Adhesives 7.4.1.1. Natural/Biological Sealants and Adhesives, By Type 7.4.1.1.1. Fibrin Sealants 7.4.1.1.2. Collagen-Based Sealants 7.4.1.1.3. Gelatin-Based Sealants 7.4.1.2.4. Albumin-Based Sealants 7.4.1.2.5. Other Natural/Biological Sealants 7.4.2.2. Natural/Biological Sealants and Adhesives, By Origin 7.4.2.2.1. Human Blood-Based Sealants and Adhesives 7.4.2.2.2. Animal-Based Sealants and Adhesives 7.4.2. Synthetic and Semi-Synthetic Sealants and Adhesives 7.4.2.1. Peg Hydrogels 7.4.2.2. Cyanoacrylate-Based Sealants and Adhesives 7.4.2.3. Urethane-Based Sealants and Adhesives 7.4.2.4. Other Synthetic and Semi-Synthetic Sealants and Adhesives 7.5. Adhesion Barriers 7.5.1. Synthetic Adhesion Barriers 7.5.1.1. Hyaluronic Acid-Based Adhesion Barriers 7.5.1.2. Regenerated Cellulose-Based Adhesion Barriers 7.5.1.3. Peg-Based Adhesion Barriers 7.5.1.4. Other Synthetic Adhesion Barriers 7.5.2. Natural Adhesion Barriers 7.5.2.1. Collagen & Protein Adhesion Barriers 7.5.2.2. Fibrin-Based Adhesion Barriers 7.6. Staple-Line Reinforcement Agents 8. Global Biosurgery Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Orthopedic Surgery 8.2. General Surgery 8.3. Neurological Surgery 8.4. Cardiovascular Surgery 8.5. Reconstructive Surgery 8.6. Gynecological Surgery 8.7. Urological Surgery 8.8. Thoracic Surgery 8.9. Others 9. Global Biosurgery Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Clinics 9.3. Others 10. North America Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Johnson & Johnson 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Baxter International Inc. 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medtronic Plc 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Becton, Dickinson & Co. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Tissue Regenix Group Plc 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Stryker Corp. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Integra Lifesciences Holdings Corp. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. CSL Ltd. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Hemostasis LLC. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Pfizer Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Cyrolife Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Zimmer Biomet 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Kuros Biosciences AG 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Orthofix Medical Inc. 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Smiths & Nephew Plc. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Tissue Regenix Group Plc 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Betatech Medical 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Meril Lifesciences Pvt. Ltd. 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Biosurgery Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biosurgery Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Biosurgery Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Biosurgery Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Bone Graft Substitutes 7.1.1. Demineralized bone matrix 7.1.2. Synthetic Bone Grafts 7.1.3. Bone Morphogenetic Proteins 7.1.4. Other Bone-Graft Substitutes 7.2. Soft-tissue attachments 7.2.1. Synthetic meshes 7.2.2. Biological meshes 7.2.2.1. Allografts 7.2.2.2. Xenografts 7.3. Hemostatic agents 7.3.1. Thrombin-based hemostatic agents 7.3.2. Oxidized regenerated cellulose-based hemostatic agents 7.3.3. Combination hemostatic agents 7.4. Surgical sealants and adhesives 7.4.1. Natural/Biological Sealants and Adhesives 7.4.1.1. Natural/Biological Sealants and Adhesives, By Type 7.4.1.1.1. Fibrin Sealants 7.4.1.1.2. Collagen-Based Sealants 7.4.1.1.3. Gelatin-Based Sealants 7.4.1.2.4. Albumin-Based Sealants 7.4.1.2.5. Other Natural/Biological Sealants 7.4.2.2. Natural/Biological Sealants and Adhesives, By Origin 7.4.2.2.1. Human Blood-Based Sealants and Adhesives 7.4.2.2.2. Animal-Based Sealants and Adhesives 7.4.2. Synthetic and Semi-Synthetic Sealants and Adhesives 7.4.2.1. Peg Hydrogels 7.4.2.2. Cyanoacrylate-Based Sealants and Adhesives 7.4.2.3. Urethane-Based Sealants and Adhesives 7.4.2.4. Other Synthetic and Semi-Synthetic Sealants and Adhesives 7.5. Adhesion Barriers 7.5.1. Synthetic Adhesion Barriers 7.5.1.1. Hyaluronic Acid-Based Adhesion Barriers 7.5.1.2. Regenerated Cellulose-Based Adhesion Barriers 7.5.1.3. Peg-Based Adhesion Barriers 7.5.1.4. Other Synthetic Adhesion Barriers 7.5.2. Natural Adhesion Barriers 7.5.2.1. Collagen & Protein Adhesion Barriers 7.5.2.2. Fibrin-Based Adhesion Barriers 7.6. Staple-Line Reinforcement Agents
8. Global Biosurgery Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Orthopedic Surgery 8.2. General Surgery 8.3. Neurological Surgery 8.4. Cardiovascular Surgery 8.5. Reconstructive Surgery 8.6. Gynecological Surgery 8.7. Urological Surgery 8.8. Thoracic Surgery 8.9. Others
9. Global Biosurgery Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Clinics 9.3. Others
10. North America Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Biosurgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Johnson & Johnson 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Baxter International Inc. 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medtronic Plc 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Becton, Dickinson & Co. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Tissue Regenix Group Plc 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Stryker Corp. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Integra Lifesciences Holdings Corp. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. CSL Ltd. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Hemostasis LLC. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Pfizer Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Cyrolife Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Zimmer Biomet 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Kuros Biosciences AG 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Orthofix Medical Inc. 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Smiths & Nephew Plc. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Tissue Regenix Group Plc 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Betatech Medical 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Meril Lifesciences Pvt. Ltd. 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics